The SRAS received incomplete information in the reports from Sponsored Projects Accounting (SPA) for November that is a primary source of information for the monthly supplemental reports we distribute.

Identifying Changes in Resubmission Applications

A special message from University of Kentucky President Eli Capilouto:

 "I gleaned the remains of my life, turned toward the hills that give me help, give me shelter, hold the sky where it belongs"

-  Jane Hicks

Over the next several months, we'll be examining and discussing the special relationship and partnership the University of Kentucky has with the Central Appalachian region.

Qing, H., Liu, Y., Zhao, Y., Aono, J., Jones, K. L., Heywood, E. B., Howatt, D., Binkley, C. M., Daugherty, A., Liang, Y. and Bruemmer, D. (2014), Deficiency of the NR4A Orphan Nuclear Receptor NOR1 in Hematopoietic Stem Cells Accelerates Atherosclerosis. STEM CELLS, 32: 2419–2429. doi: 10.1002/stem.1747 Abstract The NR4A orphan nuclear receptor NOR1 functions as a constitutively active transcription factor regulating cellular inflammation and proliferation.

Davis FM, Rateri DL, Balakrishnan A, Howatt DA, Strickland DK, Muratoglu SC, Haggerty CM, Fornwalt BK, Cassis LA, Daugherty A. Smooth Muscle Cell Deletion of Low-Density Lipoprotein Receptor-Related Protein 1 Augments Angiotensin II-Induced Superior Mesenteric Arterial and Ascending Aortic Aneurysms. Arterioscler Thromb Vasc Biol. 2014 Nov 13. pii: ATVBAHA.114.304683.  PMID: 25395615

Abstract

Thompson JC, Jayne C, Thompson J, Wilson PG, Yoder MH, Webb N, Tannock LR. A brief elevation of serum amyloid A is sufficient to increase atherosclerosis. J Lipid Res. 2014 Nov 26. pii: jlr.M054015. PMID: 25429103.

Abstract

If you are planning an NIH proposal submission for May 25, 2015 (or later), any biosketches included MUST use the new 5-page format.  Please note this represents a significant change and you are encouraged to allow sufficient lead time to prepare them.  This new format asks the investigator to provide up to five of his/her most significant contributions to science, including historical background, findings, influence and/or application of the findings on the progress of science and/or health or technology, and his/her role in the work.  For each contribution, the investigator

The Office for Human Research Protections (OHRP) recently released draft guidance on the topic, “Disclosing Reasonably Foreseeable Risks in Research Evaluating Standards of Care”, http://www.hhs.gov/ohrp/newsroom/rfc/comstdofcare.html.   Public comments on the draft guidance are encouraged and can be submitted until December 23rd.  Directions on how to submit comments can be found on the OHRP website,

Uniform Guidance Update 

A meeting will be held on Thursday, December 11 from 10:00 – 11:00 in room 102 Mining and Minerals Resources Building to update the campus community on progress towards being in compliance with the federal Uniform Guidance.    The meeting is open to all.